Single-dose pharmacokinetic study of 13-cis-retinoic acid in man

Cancer Treat Rep. 1985 Mar;69(3):275-7.

Abstract

A pharmacokinetic study of 13-cis-retinoic acid was performed in nine patients following administration of a single oral dose of 80 mg. An average lag time of 1.2 hours was observed, followed by fast absorption, with a mean half-life of 0.5 hour. Peak plasmatic concentration of 733 ng/ml occurred at 2.3 hours. The disposition profile showed a rapid distribution half-life of 1.3 hours and a terminal elimination half-life of 24.7 hours. No 13-cis-retinoic acid was detected unchanged in urine. An important interpatient variability was noted.

MeSH terms

  • Administration, Oral
  • Chromatography, High Pressure Liquid
  • Drug Evaluation
  • Half-Life
  • Head and Neck Neoplasms / blood
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / metabolism*
  • Humans
  • Isotretinoin
  • Kinetics
  • Male
  • Tretinoin / blood
  • Tretinoin / metabolism*
  • Tretinoin / therapeutic use

Substances

  • Tretinoin
  • Isotretinoin